Novo Nordisk A/S
NYSE: NVO
$134.88
+$2.82 (+2.1%)
Closing Price on September 19, 2024
NVO Articles
nationsonline.orgEurope is in the pits. It is in a real recession, even if some countries have not officially declared it a recession. And the falling Euro makes the imports that much more...
Published:
Last Updated:
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the biggest public merger rumors out there. At least that is the belief of Wall...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday. American International Group (NYSE: AIG) Raised to Outperform at...
Published:
Last Updated:
These are the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. Anadarko Petroleum Corp. (NYSE: APC) Reiterated Hold at Argus....
Published:
Last Updated:
These are some of this Monday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Advance Micro Devices, Inc. (NYSE: AMD) Raised to Neutral at Macquarie. Avago...
Published:
Last Updated:
These are some of this Thursday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Agilent Technologies, Inc. (NYSE: A) Raised to Buy at Stifel Nicolaus....
Published:
Last Updated:
These are the top day trader and active trader alert stocks. We have more details and analysis via a link to each story over at VSInvestor.com: Apple Inc.(NASDAQ: AAPL) is one we are watching the...
Published:
Last Updated:
These are Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Advanced Micro Devices (NYSE: AMD) Raised to Outperform at FBR. Comerica (NYSE: CMA)...
Published:
Last Updated:
Wasn’t it just last week that we were up eight days in a row on the DJIA? And now we have a sell-the-news reaction to the recent growth numbers. Maybe it is because we ran too far too fast and...
Published:
Last Updated:
NYSE Euronext has begun trading a new ETF this week that is meant to track the large companies throughout the Nordic region. This seeks to track the FTSE Nordic 30 Index, which is comprised of the...
Published:
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a recent dig down for...
Published:
Last Updated:
Everyone is on hold for jobs data, but there are still pre-market research calls. These are the top ten analyst calls we saw for upgrades and downgrades this Friday morning: Crocs (CROX) Raised to...
Published:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
Published: